Cantor Out Positive On Jazz Pharmaceutical, Says Next Leg Of Sleep Franchise Growth Is Established With NDA Filing of JZP-110; Firm Believes pitolisant Is Unlikely To Mount A Credible Competition To Xyrem or JZP-110